TY - JOUR
T1 - Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis
T2 - Effects of sulfasalazine in vivo and in vitro
AU - Rubinstein, A.
AU - Das, K. M.
AU - Melamed, J.
AU - Murphy, R. A.
PY - 1978/12/1
Y1 - 1978/12/1
N2 - Comparative analysis of the systemic immunity revealed similarities between ulcerative colitis and idiopathic proctitis. In the active stage of both diseases, circulating complement receptor positive cells were increased whereas T-cell percentages and lymphocyte functions were decreased. In severe forms of ulcerative colitis and idiopathic proctitis circulating EAC-phagocytosing esterase positive cells, indicative of activated monocytes, were demonstrated. Successful treatment with salicylazosulfapyridine (SASP) reversed these immunological changes. Incubation of SASP and its metabolites with leucocytes from patients and control subjects, in concentration similar to those demonstrated in sera from patients treated with SASP, did not alter the immunological changes.
AB - Comparative analysis of the systemic immunity revealed similarities between ulcerative colitis and idiopathic proctitis. In the active stage of both diseases, circulating complement receptor positive cells were increased whereas T-cell percentages and lymphocyte functions were decreased. In severe forms of ulcerative colitis and idiopathic proctitis circulating EAC-phagocytosing esterase positive cells, indicative of activated monocytes, were demonstrated. Successful treatment with salicylazosulfapyridine (SASP) reversed these immunological changes. Incubation of SASP and its metabolites with leucocytes from patients and control subjects, in concentration similar to those demonstrated in sera from patients treated with SASP, did not alter the immunological changes.
UR - http://www.scopus.com/inward/record.url?scp=0018081331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018081331&partnerID=8YFLogxK
M3 - Article
C2 - 31252
AN - SCOPUS:0018081331
SN - 0009-9104
VL - 33
SP - 217
EP - 224
JO - Clinical and Experimental Immunology
JF - Clinical and Experimental Immunology
IS - 2
ER -